Synpromics’ products comprise, or are based on, patentable synthetic promoters that are designed to regulate genes in any cell type or any environmental condition.

Synpromics' products vastly improve upon the natural promoters on which the entire biotech industry currently relies to regulate genes. The company's technology allows it to leverage a cell's transcriptome, or gene expression profile, to design and construct synthetic promoters that are only active in a specific cell type that is subject to a particular condition of interest.

This has not been possible until now and consequently there is enormous potential for Synpromics to use its technology to transform the entire Biotech sector. The company is currently active in a number of diverse fields, including: Cell & Gene Therapy, Biologics Bioprocessing, Industrial Biotechnology, Agricultural Biotechnology and Cell-Based Assays. Additionally, we are open to applying our technology to new disciplines and welcome enquiries from organisations wishing to improve gene expression in their model system.

Synthetic Promoter Design

Proprietary Promoter Design Process

Cell and Gene Therapy

Solving the challenge of targeted expression and enabling the next generation of genetic therapeutics

Patentable synthetic promoters for cell & gene therapy, enable specificity, enhanced therapeutic efficacy & increased clinical safety.

Read more

Vector Bioprocessing

​Creating next generation viral vector production systems to deliver higher titres and enable industrial-scale manufacturing of gene therapy products

Developing constitutive & inducible promoters for the creation of retroviral, lentiviral & AAV vector stable producer cell lines.

Read more


Enhancing the manufacture of biologics using promoters tailored to specific producer cell lines and the recombinant protein of interest

Improved bioprocessing yields, enhanced expression & increased extracellular protein secretion, in mammalian, yeast or bacterial systems.

Read more